Cover Image
市場調查報告書

Vaxine Pty Ltd的產品平台分析

Vaxine Pty Ltd - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256063
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Vaxine Pty Ltd的產品平台分析 Vaxine Pty Ltd - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 24 Pages
簡介

Vaxine Pty Ltd,是開發治療傳染病及慢性疾病用疫苗的生物科技企業。該公司正在開發流感疫苗,B型肝炎疫苗及日本腦炎疫苗。

本報告提供Vaxine Pty Ltd的產品開發平台現狀及各開發階段比較分析,提供您藥物簡介,開發平台分析與最新趨勢,現在暫停中的計劃等資訊。

Vaxine Pty Ltd的基本資料

Vaxine Pty Ltd概要

  • 主要資訊
  • 企業資料

Vaxine Pty Ltd:R&D概要

  • 主要的治療範圍

Vaxine Pty Ltd:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Vaxine Pty Ltd:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Vaxine Pty Ltd:藥物簡介

  • H1N第一型流感疫苗
  • 季節性流感疫苗
  • B型肝炎預防疫苗
  • 流感疫苗
  • B型肝炎疫苗
  • 日本腦炎疫苗

Vaxine Pty Ltd:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

Vaxine Pty Ltd:暫停中的計劃

Vaxine Pty Ltd:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07233CDB

Summary

Global Markets Direct's, 'Vaxine Pty Ltd - Product Pipeline Review - 2015', provides an overview of the Vaxine Pty Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vaxine Pty Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Vaxine Pty Ltd including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Vaxine Pty Ltd's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Vaxine Pty Ltd's pipeline products

Reasons to buy

  • Evaluate Vaxine Pty Ltd's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Vaxine Pty Ltd in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Vaxine Pty Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Vaxine Pty Ltd and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vaxine Pty Ltd
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Vaxine Pty Ltd and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vaxine Pty Ltd Snapshot
    • Vaxine Pty Ltd Overview
    • Key Information
    • Key Facts
  • Vaxine Pty Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Vaxine Pty Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Vaxine Pty Ltd - Pipeline Products Glance
    • Vaxine Pty Ltd - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Vaxine Pty Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Vaxine Pty Ltd - Drug Profiles
    • influenza [strain H1N1] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • seasonal influenza (trivalent, split virion) vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hepatitis B vaccine prophylactic
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • influenza [strain H5N1] (split virion) vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hepatitis B vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • japanese encephalitis vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Vaxine Pty Ltd - Pipeline Analysis
  • Vaxine Pty Ltd - Pipeline Products by Target
  • Vaxine Pty Ltd - Pipeline Products by Route of Administration
  • Vaxine Pty Ltd - Pipeline Products by Molecule Type
  • Vaxine Pty Ltd - Dormant Projects
  • Vaxine Pty Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vaxine Pty Ltd, Key Information
  • Vaxine Pty Ltd, Key Facts
  • Vaxine Pty Ltd - Pipeline by Indication, 2015
  • Vaxine Pty Ltd - Pipeline by Stage of Development, 2015
  • Vaxine Pty Ltd - Monotherapy Products in Pipeline, 2015
  • Vaxine Pty Ltd - Phase I, 2015
  • Vaxine Pty Ltd - Preclinical, 2015
  • Vaxine Pty Ltd - Pipeline by Target, 2015
  • Vaxine Pty Ltd - Pipeline by Route of Administration, 2015
  • Vaxine Pty Ltd - Pipeline by Molecule Type, 2015
  • Vaxine Pty Ltd - Dormant Developmental Projects,2015
  • Vaxine Pty Ltd, Subsidiaries

List of Figures

  • Vaxine Pty Ltd - Pipeline by Top 10 Indication, 2015
  • Vaxine Pty Ltd - Pipeline by Stage of Development, 2015
  • Vaxine Pty Ltd - Monotherapy Products in Pipeline, 2015
  • Vaxine Pty Ltd - Pipeline by Top 10 Target, 2015
  • Vaxine Pty Ltd - Pipeline by Top 10 Route of Administration, 2015
  • Vaxine Pty Ltd - Pipeline by Top 10 Molecule Type, 2015
Back to Top